Deniz 
This $200 million Tether strategic investment in Blackrock Neurotech is a first for the healthcare industry. Blackrock Neurotech specializes in brain-computer interface (BCI) technology.
Tether Evo, the stablecoin powerhouse, and its new venture subsidiary announce that it has become a majority stakeholder in Blackrock Neurotech, enabling a key step towards creating medical treatments for those with paralysis, neurological issues, or lost function.
Founded in 2008, Blackrock Neurotech was the first to develop BCI technology that allows patients to control devices with their minds.
The company’s technology allows people to use robotic limbs, move wheelchairs, and communicate using their brain impulses.
“Tether investments use stablecoin reserves, and company profits are used for other investments,” stated CEO Paolo Ardoino.
The investment made by Tether aims at fastening the commercialization and roll-out of the medical solutions of Blackrock Neurotech, which have enhanced over 40 lives. The funds will also fund research and development for Blackrock Neurotech, ensuring that it remains in the lead in the BCI technology market.
The CEO of Tether, Paolo Ardoino, hailed the agreement, which signified Tether’s dedication to the development of disruptive technology.
Ardoino stated:
“Blackrock Neurotech is just the beginning of our journey through Tether Evo to venture into projects that redefine the boundaries of what’s possible at the intersection of technological innovation and human potential.”
Also, Ardoino brought attention to the fact that Blackrock Neurotech’s BCI technology has the ability to completely transform the fields of communication, rehabilitation, and cognitive enhancement:
“Tether has long believed in nurturing emerging technologies that have transformative capabilities, and the Brain-Computer-Interfaces of Blackrock Neurotech have the potential to open new realms of communication, rehabilitation, and cognitive enhancement.”
Blackrock Neurotech co-founder Dr. Florian Solzbacher thanked Tether profusely for their assistance. He highlighted how both firms are committed to improving healthcare and the lives of millions of people throughout the world in the long run.
“My life’s dream has been to help and restore function in people who lost it and to advance technologies that revolutionize healthcare and the world around us,” Solzbacher, co-founder of Blackrock Neurotech, said.
Solzbacher added,
“This ambitious, long-term endeavour requires dedicated and visionary partners. With its commitment to seeking out and nurturing technology that will help many people and push mankind forward, we couldn’t dream of a better partner than Tether to bring our shared vision to life.”